Physician profile
Devora Singer
NPI 1770827974
$5,102.24
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,161 · 2022: $3,291 · 2023: $564 · 2024: $86.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $650.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,791.04 | 2021-2023 | Interstim |
| Janssen Biotech, INC. | $577.34 | 2021-2024 | Erleada, Akeega, Balversa |
| Urovant Sciences INC | $550.79 | 2021-2022 | |
| Abbvie INC. | $411.01 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $311.51 | 2021-2023 | |
| Astellas Pharma US INC | $311.14 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $251.49 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $166.24 | 2021-2022 | |
| Teleflex LLC | $138.74 | 2022 | |
| Sumitomo Pharma America, INC. | $124.65 | 2023 | Gemtesa, Orgovyx |
| Merck Sharp & Dohme LLC | $102.23 | 2021-2022 | |
| Pfizer INC. | $88.97 | 2021-2022 | |
| Amgen INC. | $50.44 | 2022-2023 | Xgeva |
| Convatec INC. | $47.92 | 2021-2022 | |
| Allergan, INC. | $44.92 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $38.61 | 2021-2022 | |
| 180 Medical, INC. | $21.71 | 2022 | |
| Foundation Medicine, INC. | $20.78 | 2022 | |
| Antares Pharma, INC. | $20.10 | 2022 | |
| Eisai INC. | $18.76 | 2022 | |
| Curonix LLC | $13.85 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devora Singer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.